Invention Grant
- Patent Title: Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response
-
Application No.: US15205203Application Date: 2016-07-08
-
Publication No.: US10434155B2Publication Date: 2019-10-08
- Inventor: Hideho Okada , Walter J. Storkus
- Applicant: University of Pittsburgh—Of the Commonwealth System of Higher Education
- Applicant Address: US PA Pittsburgh
- Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
- Current Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
- Current Assignee Address: US PA Pittsburgh
- Agency: Leydig, Voit & Mayer, Ltd.
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K39/00 ; C07K14/715
Abstract:
The invention provides a peptide derived from the interleukin-13 receptor α2, which serves as a HLA-A2-restricted cytotoxic T lymphocyte (CTL) epitope. The invention can be used as a vaccine for glioma and can be formulated into compositions for medical or veterinary use. In addition, the invention provides the use of a peptide derived from the Eph family of tyrosine kinase receptors which can be also used as a vaccine for glioma and can be formulated into compositions for medical or veterinary use.
Public/Granted literature
- US20170151317A1 PEPTIDE ANALOGS CAPABLE OF ENHANCING STIMULATION OF A GLIOMA-SPECIFIC CTL RESPONSE Public/Granted day:2017-06-01
Information query
IPC分类:
